GIANT BIOGENE (02367.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec15

Juzi Bio repurchased 400,000 shares for about HK$13.9173 million

12:31

Juzi Biotech Focuses on New Share Repurchase Plan and Positive Broker Ratings

05:08

Dec13

UBS Analyst Maintains Hold Rating on Giant Biogene

01:21

Dec12

Juzi Biotech repurchased 400,000 shares for HKD 14.0364 million

11:01

Dec11

UBS downgrades ZTO Bio to neutral

02:31

CITIC Securities Downgrades JuZiBio's 2025 Forecast but Maintains 'Buy' Rating

02:26

Schedules & Filings

Schedules

Filings

Aug29

Distribution Plan(CST)

Special dividend 0.6475 HKD, Cash dividend 0.6584 HKD

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.703 B, Net Income 646.91 M, EPS 0.6184

Jun18

Distribution Plan(CST)

Special dividend 0.6475 HKD, Cash dividend 0.6584 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More